Literature DB >> 20016205

Stainless steel ions stimulate increased thrombospondin-1-dependent TGF-beta activation by vascular smooth muscle cells: implications for in-stent restenosis.

Manuel A Pallero1, Melissa Talbert Roden, Yiu-Fai Chen, Peter G Anderson, Jack Lemons, Brigitta C Brott, Joanne E Murphy-Ullrich.   

Abstract

BACKGROUND/AIMS: Despite advances in stent design, in-stent restenosis (ISR) remains a significant clinical problem. All implant metals exhibit corrosion, which results in release of metal ions. Stainless steel (SS), a metal alloy widely used in stents, releases ions to the vessel wall and induces reactive oxygen species, inflammation and fibroproliferative responses. The molecular mechanisms are unknown. TGF-beta is known to be involved in the fibroproliferative responses of vascular smooth muscle cells (VSMCs) in restenosis, and TGF-beta antagonists attenuate ISR. We hypothesized that SS ions induce the latent TGF-beta activator, thrombospondin-1 (TSP1), through altered oxidative signaling to stimulate increased TGF-beta activation and VSMC phenotype change.
METHODS: VSMCs were treated with SS metal ion cocktails, and morphology, TSP1, extracellular matrix production, desmin and TGF-beta activity were assessed by immunoblotting.
RESULTS: SS ions stimulate the synthetic phenotype, increased TGF-beta activity, TSP1, increased extracellular matrix and downregulation of desmin in VSMCs. Furthermore, SS ions increase hydrogen peroxide and decrease cGMP-dependent protein kinase (PKG) signaling, a known repressor of TSP1 transcription. Catalase blocks SS ion attenuation of PKG signaling and increased TSP1 expression.
CONCLUSIONS: These data suggest that ions from stent alloy corrosion contribute to ISR through stimulation of TSP1-dependent TGF-beta activation. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20016205      PMCID: PMC2895758          DOI: 10.1159/000265565

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  69 in total

1.  Increased corrosion resistance of stent materials by converting current surface film of polycrystalline oxide into amorphous oxide.

Authors:  C C Shih; S J Lin; K H Chung; Y L Chen; Y Y Su
Journal:  J Biomed Mater Res       Date:  2000-11

2.  Levels of hydrogen peroxide in tissues adjacent to failing implantable devices may play an active role in cytokine production.

Authors:  M Tucci; R Baker; H Benghuzzi; J Hughes
Journal:  Biomed Sci Instrum       Date:  2000

3.  Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1.

Authors:  M Emura; A Ochiai; M Horino; W Arndt; K Kamino; S Hirohashi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-02       Impact factor: 2.416

4.  Macrophage responses to vascular stent coatings.

Authors:  M Ball; A O'Brien; F Dolan; G Abbas; J A McLaughlin
Journal:  J Biomed Mater Res A       Date:  2004-09-01       Impact factor: 4.396

5.  In vitro host response assessment of biomaterials for cardiovascular stent manufacture.

Authors:  Matteo Santin; Lyuba Mikhalovska; Andrew W Lloyd; Sergey Mikhalovsky; Louise Sigfrid; Stephen P Denyer; Susanna Field; Dennis Teer
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

Review 6.  Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology.

Authors:  J E Murphy-Ullrich; M Poczatek
Journal:  Cytokine Growth Factor Rev       Date:  2000 Mar-Jun       Impact factor: 7.638

Review 7.  Cell signaling by reactive nitrogen and oxygen species in atherosclerosis.

Authors:  R P Patel; D Moellering; J Murphy-Ullrich; H Jo; J S Beckman; V M Darley-Usmar
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

Review 8.  The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury.

Authors:  Paul Bornstein; Azin Agah; Themis R Kyriakides
Journal:  Int J Biochem Cell Biol       Date:  2004-06       Impact factor: 5.085

9.  Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-beta activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2.

Authors:  Shuxia Wang; Jim Skorczewski; Xu Feng; Lin Mei; Joanne E Murphy-Ullrich
Journal:  J Biol Chem       Date:  2004-06-07       Impact factor: 5.157

Review 10.  Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis.

Authors:  David J Grainger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-29       Impact factor: 8.311

View more
  16 in total

1.  Substrate-induced phenotypic switches of human smooth muscle cells: an in vitro study of in-stent restenosis activation pathways.

Authors:  Anna L Guildford; Helen J S Stewart; Christopher Morris; Matteo Santin
Journal:  J R Soc Interface       Date:  2010-11-24       Impact factor: 4.118

Review 2.  Matricellular proteins and biomaterials.

Authors:  Aaron H Morris; Themis R Kyriakides
Journal:  Matrix Biol       Date:  2014-03-20       Impact factor: 11.583

3.  Enhanced biocompatibility of CD47-functionalized vascular stents.

Authors:  Joshua B Slee; Ivan S Alferiev; Chandrasekaran Nagaswami; John W Weisel; Robert J Levy; Ilia Fishbein; Stanley J Stachelek
Journal:  Biomaterials       Date:  2016-02-08       Impact factor: 12.479

Review 4.  Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis.

Authors:  Teruo Inoue; Kevin Croce; Toshifumi Morooka; Masashi Sakuma; Koichi Node; Daniel I Simon
Journal:  JACC Cardiovasc Interv       Date:  2011-10       Impact factor: 11.195

5.  Functional behavior and gene expression of magnetic nanoparticle-loaded primary endothelial cells for targeting vascular stents.

Authors:  Fatema Tuj Zohra; Mikhail Medved; Nina Lazareva; Boris Polyak
Journal:  Nanomedicine (Lond)       Date:  2015-05       Impact factor: 5.307

Review 6.  Restenosis after PCI. Part 1: pathophysiology and risk factors.

Authors:  J Wouter Jukema; Jeffrey J W Verschuren; Tarek A N Ahmed; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2011-09-13       Impact factor: 32.419

7.  Stent thrombosis: understanding and managing a critical problem.

Authors:  Julio F Marchini; Andre Manica; Kevin Croce
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-02

8.  Glucose downregulation of PKG-I protein mediates increased thrombospondin1-dependent TGF-{beta} activity in vascular smooth muscle cells.

Authors:  Shuxia Wang; Thomas M Lincoln; Joanne E Murphy-Ullrich
Journal:  Am J Physiol Cell Physiol       Date:  2010-02-17       Impact factor: 4.249

9.  Anti-atherogenic effect of trivalent chromium-loaded CPMV nanoparticles in human aortic smooth muscle cells under hyperglycemic conditions in vitro.

Authors:  Rituparna Ganguly; Amy M Wen; Ashley B Myer; Tori Czech; Soumyadip Sahu; Nicole F Steinmetz; Priya Raman
Journal:  Nanoscale       Date:  2016-03-28       Impact factor: 7.790

Review 10.  The complex regulation of TGF-β in cardiovascular disease.

Authors:  Santiago Redondo; Jorge Navarro-Dorado; Marta Ramajo; Úrsula Medina; Teresa Tejerina
Journal:  Vasc Health Risk Manag       Date:  2012-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.